Showing results (731-740 of 781) with videos related to
Sort By:
Pageof 79
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Extraosseous osteosarcoma: response to treatment and long-term outcomeSyed A Ahmad, Shreyaskumar R Patel, Matthew T Ballo, et al.American Journal of Clinical Oncology|December 4, 2025
Primary Synovial Sarcoma of the Abdomen and PelvisRiddhi R Patel, Jonathan Feit, Grace Werling, et al.Annals of Emergency Medicine|July 2, 2019
Baseline Performance of Real-World Clinical Practice Within a Statewide Emergency Medicine Quality Network: The Michigan Emergency Department Improvement Collaborative (MEDIC)Keith E Kocher, Rajan Arora, Benjamin S Bassin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomasPeter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.Annals of Internal Medicine|May 1, 1997
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancerS Vadhan-Raj, L J Murray, C Bueso-Ramos, et al.Cancer Medicine|September 24, 2022
Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcomaPrapassorn Thirasastr, Heather Lin, Behrang Amini, et al.Nature Communications|October 13, 2021
Relationship of insect biomass and richness with land use along a climate gradientJohannes Uhler, Sarah Redlich, Jie Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomasJ B Fleming, R S Berman, S C Cheng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033Charles D Blanke, Cathryn Rankin, George D Demetri, et al.Plos One|September 8, 2017
SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functionsLei L Chen, Jing Zhu, Jonathan Schumacher, et al.Pageof 79